A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC | MicrobiomeTrials← Back to trialsNCT05849298
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-01-03Est. Completion: 2026-12-23
Enrollment target: 49 participants Locations- Rocky Mountain Cancer Centers, Denver, Colorado, United States
- University Cancer and Blood Center LLC, Athens, Georgia, United States
- Urology Of Indiana, Indianapolis, Indiana, United States
- Unity Point Clinic, Des Moines, Iowa, United States
- Urology Cancer Center PC, Omaha, Nebraska, United States
- Associated Med Professionals of NY, Syracuse, New York, United States
- Oregon Urology Institute, Springfield, Oregon, United States
- Wellspan York Hospital, York, Pennsylvania, United States
- Univ of Texas Southwest Med Center, Dallas, Texas, United States
- Rio Grande Urology, El Paso, Texas, United States
- Houston Methodist Hospital, Houston, Texas, United States
- Novartis Investigative Site, São Paulo, São Paulo, Brazil
- Novartis Investigative Site, São Paulo, São Paulo, Brazil
- Novartis Investigative Site, Toronto, Ontario, Canada
- Novartis Investigative Site, Montreal, Quebec, Canada
- Novartis Investigative Site, Montreal, Quebec, Canada
- Novartis Investigative Site, Olomouc, Czechia
Other microbiome trials you might be interested in
Prostate Cancer
In this exploratory, single-arm, nonrandomized trial, the impact of the preoperative utilization of the glucagon-like pe…
Gilbert, United StatesEst. completion May 2028
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid TumorUrinary Bladder NeoplasmTriple Negative Breast CancerNon-small Cell Lung CancerEsophageal CancerPancreatic Cancer
Novartis Investigative Site, Angers, FranceNovartis Investigative Site, Brest, FranceNovartis Investigative Site, Strasbourg, FranceNovartis Investigative Site, Berlin, GermanyNovartis Investigative Site, Genova, GE, ItalyNovartis Investigative Site, Milan, MI, ItalyNovartis Investigative Site, Roma, RM, ItalyNovartis Investigative Site, Naples, ItalyNovartis Investigative Site, Kielce, PolandNovartis Investigative Site, Singapore, SingaporeNovartis Investigative Site, Seoul, South KoreaNovartis Investigative Site, Seoul, South KoreaNovartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, SpainNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Madrid, SpainOvarian Cancer
Cervical Cancer
Head and Neck Squamous Cell Carcinoma
Prostate Cancer
Renal Pelvis Cancer
Bladder Cancer
The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in particip…
Duarte, United StatesEst. completion May 2027
Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design…
Los Angeles, United StatesEst. completion Jun 2028